Erica L. Mayer, MD, MPH
PeerWho Is the Best Candidate for Sequencing Sacituzumab Govitecan Before T-DXd in HR+ Breast Cancer?
Sarah Sammons, MD
PeerErica L. Mayer, MD, MPH
PeerSarah Sammons, MD
PeerErica L. Mayer, MD, MPH
PeerSarah Sammons, MD
PeerHow Do Brain Metastases Affect Your Choice of Systemic Treatment in a Patient with HR+/HER2-low MBC?
Sarah Sammons, MD
PeerBispecific Antibodies in FL
NCCN Guideline Updates in DLBCL
Antibody-Drug Conjugates in FL